ACADIA PHARMACEUTICALS INC (ACAD) Institutional Shareholders

ACADIA PHARMACEUTICALS INC (ACAD) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $4.26B in ACAD holdings during the latest filing period.

Baker Bros. Advisors Lp is currently the largest disclosed institutional shareholder of ACAD tracked by InsiderSet, reporting ownership valued at approximately $1.09B in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $1.18B, representing an estimated gain of +8.50% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 65% of the total disclosed ACAD value among the investors covered in this analysis. Major shareholders include Baker Bros. Advisors Lp, Blackrock, Inc., State Street Corp, and several other long-term asset managers with concentrated positions in ACADIA PHARMACEUTICALS INC (ACAD).

This page ranks the largest institutional ACAD shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

340

Total Reported Value

$4.26B

Largest Holder

Baker Bros. Advisors Lp

Largest Position

$1.09B

Insider Transactions (90d)

8

Latest Filing Quarter

Q2 2026

New Institutional Positions

44

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Baker Bros. Advisors Lp5.44%42,912,904$1,085,696,471$1,177,959,215+$92,262,744+8.50%
Blackrock, Inc.0.01%22,515,173$569,633,876$618,041,499+$48,407,623+8.50%
State Street Corp0.01%9,076,212$229,628,164$249,142,019+$19,513,855+8.50%
Vanguard Portfolio Management Llc0.01%8,838,450$223,612,785$242,615,453+$19,002,668+8.50%
Rtw Investments, Lp1.54%7,144,524$180,756,457$196,117,184+$15,360,727+8.50%
Vanguard Capital Management Llc0.00%5,763,750$145,822,875$158,214,938+$12,392,063+8.50%
Dimensional Fund Advisors Lp0.02%3,694,988$93,482,749$101,427,421+$7,944,672+8.50%
Geode Capital Management, Llc0.00%3,358,129$84,977,229$92,180,641+$7,203,412+8.48%
Palo Alto Investors Lp10.01%2,864,096$72,461,629$78,619,435+$6,157,806+8.50%
Goldman Sachs Group Inc0.01%2,580,115$65,276,910$70,824,157+$5,547,247+8.50%
Qube Research & Technologies Ltd0.07%2,446,610$61,899,233$67,159,445+$5,260,212+8.50%
Point72 Asset Management, L.P.0.09%2,433,168$61,559,150$66,790,462+$5,231,312+8.50%
Citadel Advisors Llc0.03%2,182,177$55,209,078$59,900,759+$4,691,681+8.50%
Pictet Asset Management Holding Sa0.05%1,983,198$50,146,450$54,438,785+$4,292,335+8.56%
Arrowstreet Capital, Limited Partnership0.02%1,969,445$49,826,959$54,061,265+$4,234,306+8.50%
Marshall Wace, Llp0.04%1,764,838$44,650,402$48,444,803+$3,794,401+8.50%
D. E. Shaw & Co., Inc.0.03%1,697,937$42,957,806$46,608,371+$3,650,565+8.50%
Braidwell Lp1.54%1,646,399$41,653,895$45,193,653+$3,539,758+8.50%
Norges Bank0.00%1,623,308$41,069,692$44,559,805+$3,490,113+8.50%
Frazier Life Sciences Management, L.P.0.79%1,438,198$36,386,409$39,478,535+$3,092,126+8.50%
Northern Trust Corp0.00%1,367,422$34,595,776$37,535,734+$2,939,958+8.50%
Nuveen, Llc0.01%1,348,192$34,109,259$37,007,870+$2,898,611+8.50%
Artisan Partners Limited Partnership0.05%1,325,134$33,525,890$36,374,928+$2,849,038+8.50%
Bank Of America Corp0.00%1,300,385$32,899,740$35,695,568+$2,795,828+8.50%
Renaissance Technologies LLCJim Simons0.04%1,282,596$32,449,679$35,207,260+$2,757,581+8.50%
Charles Schwab Investment Management Inc0.00%1,206,336$30,520,301$33,113,923+$2,593,622+8.50%
Allspring Global Investments Holdings, Llc0.04%1,132,566$28,540,663$31,088,937+$2,548,274+8.93%
Rockefeller Capital Management L.P.0.04%1,015,420$25,690,127$27,873,279+$2,183,152+8.50%
Morgan Stanley0.00%946,639$23,949,976$25,985,241+$2,035,265+8.50%
Two Sigma Investments, Lp0.02%926,992$23,452,898$25,445,930+$1,993,032+8.50%
Vanguard Fiduciary Trust Co0.01%912,370$23,082,961$25,044,557+$1,961,596+8.50%
Massachusetts Financial Services Co0.01%855,435$21,642,506$23,481,691+$1,839,185+8.50%
Invesco Ltd.0.00%810,462$20,504,689$22,247,182+$1,742,493+8.50%
Principal Financial Group Inc0.01%789,196$19,966,658$21,663,430+$1,696,772+8.50%
Bank Of New York Mellon Corp0.00%760,629$19,243,919$20,879,266+$1,635,347+8.50%
Allianz Asset Management Gmbh0.02%757,195$19,157,034$20,785,003+$1,627,969+8.50%
Panagora Asset Management Inc0.06%710,906$17,985,922$19,514,370+$1,528,448+8.50%
Fisher Asset Management, Llc0.01%699,230$17,690,535$19,193,864+$1,503,329+8.50%
Fred Alger Management, Llc0.05%648,611$16,409,858$17,804,372+$1,394,514+8.50%
Rice Hall James & Associates, Llc0.76%618,887$15,657,841$16,988,448+$1,330,607+8.50%
Ameriprise Financial Inc0.00%606,536$15,348,144$16,649,413+$1,301,269+8.48%
Millennium Management Llc0.01%589,924$14,925,077$16,193,414+$1,268,337+8.50%
Manufacturers Life Insurance Company, The0.01%583,852$14,771,456$16,026,737+$1,255,281+8.50%
Aqr Capital Management Llc0.00%522,749$13,225,551$14,349,460+$1,123,909+8.50%
Adage Capital Partners Gp, L.L.C.0.02%510,000$12,903,000$13,999,500+$1,096,500+8.50%
Glenmede Trust Co Na0.05%488,546$12,360,212$13,410,588+$1,050,376+8.50%
Hudson Bay Capital Management Lp0.06%465,000$11,764,500$12,764,250+$999,750+8.50%
Ubs Group Ag0.00%460,053$11,639,341$12,628,455+$989,114+8.50%
Jupiter Asset Management Ltd0.06%458,466$11,599,190$12,584,892+$985,702+8.50%
Public Sector Pension Investment Board0.03%435,375$11,014,988$11,951,044+$936,056+8.50%
Showing 50 of 340

Frequently asked questions about ACAD

  • Who owns the most ACAD stock?

    The largest holders of ACAD are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ACADIA PHARMACEUTICALS INC (ACAD).

  • Is ACAD widely held by superinvestors?

    Many widely followed stocks like ACAD appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ACAD is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.